UCLB spinout company IXICO expands into Digital Healthcare
Published on 16 October 2013
IXICO Limited, the medical image analysis company whose founders included Professors David Hawkes and Derek Hill from the Centre for Medical Image Computing at UCL was recently acquired by Phytopharm plc in a reverse takeover transaction.
Since its formation in 2005, IXICO has established itself as a provider of medical image analysis services to the clinical trials market and more recently has sought to move into the ‘digital healthcare’ space through the development of products to support dementia diagnosis. The funds resulting from the Phytopharm transaction will be used to support the further development of these activities.
Dr Steven Schooling from UCLB commented “We look forward to seeing Ixico grow its clinical trial services revenues and also develop clinically relevant technology solutions in the increasingly important area of neuro-degeneration”
Founded by Professor Derek Hill and Professor David Hawkes from the Centre for Medical Image Computing in conjunction with colleagues at Imperial College, Ixico provides image analysis services to the pharmaceutical industry. By coupling image analysis technology with expertise in image acquisition, the company is able to provide automated, scalable and authoritative information extraction solutions. Ixico will improve the quality and effectiveness of therapeutic interventions, both under development and in clinical use, through an automated service to extract relevant clinical information from images.
UCLB is a leading technology transfer company that supports and commercialises research and innovations arising from UCL, one of the UK’s top research-led universities.
UCLB has a successful track record and a strong reputation for identifying and protecting promising new technologies and innovations from UCL academics. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from the laboratory to market.
UCLB supports UCL’s Grand Challenges of increasing UCL’s positive impact on and contribution to Global Health, Sustainable Cities, Intercultural Interaction and Human Wellbeing.
For further information, please visit www.uclb.com
Print friendly version of UCLB spinout company IXICO expands into Digital Healthcare